Bristol Myers Squibb Co (BMY) stock
BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3029% below fair value
$61.35−1.58 (-2.51%)
Close on Nov 17, 2026Market cap $125.41BP/E 13.6Yield 4.06%
Bristol Myers Squibb profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Bristol Myers Squibb's profit margin for the twelve months ending Sep 30, 2026 was 18.5%. For fiscal 2025 it was 14.6%, against -18.5% the year before. The highest annual figure on record is 56.4% in fiscal 2009.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.6% | +33.2 |
| FY2024 | Dec 31, 2024 | -18.5% | −36.4 |
| FY2023 | Dec 31, 2023 | 17.8% | +4.1 |
| FY2022 | Dec 31, 2022 | 13.7% | −1.4 |
| FY2021 | Dec 31, 2021 | 15.1% | +36.3 |
| FY2020 | Dec 31, 2020 | -21.2% | −34.4 |
| FY2019 | Dec 31, 2019 | 13.2% | −8.7 |
| FY2018 | Dec 31, 2018 | 21.8% | +17.0 |
| FY2017 | Dec 31, 2017 | 4.8% | −18.1 |
| FY2016 | Dec 31, 2016 | 22.9% | +13.5 |
| FY2015 | Dec 31, 2015 | 9.5% | −3.2 |
| FY2014 | Dec 31, 2014 | 12.6% | −3.0 |
| FY2013 | Dec 31, 2013 | 15.6% | +4.5 |
| FY2012 | Dec 31, 2012 | 11.1% | −6.3 |
| FY2011 | Dec 31, 2011 | 17.5% | +1.5 |
| FY2010 | Dec 31, 2010 | 15.9% | −40.5 |
| FY2009 | Dec 31, 2009 | 56.4% | +26.8 |
| FY2008 | Dec 31, 2008 | 29.6% | +15.8 |
| FY2007 | Dec 31, 2007 | 13.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 16.5% | −1.5 |
| Q2 FY2026 | Jun 30, 2026 | 25.6% | +14.9 |
| Q1 FY2026 | Mar 31, 2026 | 23.3% | +1.4 |
| Q4 FY2025 | Dec 31, 2025 | 8.7% | +8.1 |
| Q3 FY2025 | Sep 30, 2025 | 18.0% | +7.8 |
| Q2 FY2025 | Jun 30, 2025 | 10.7% | −3.1 |
| Q1 FY2025 | Mar 31, 2025 | 21.9% | +122.3 |
| Q4 FY2024 | Dec 31, 2024 | 0.6% | −14.8 |
| Q3 FY2024 | Sep 30, 2024 | 10.2% | −7.4 |
| Q2 FY2024 | Jun 30, 2024 | 13.8% | −4.7 |
| Q1 FY2024 | Mar 31, 2024 | -100.4% | −120.3 |
| Q4 FY2023 | Dec 31, 2023 | 15.4% | −2.4 |
| Q3 FY2023 | Sep 30, 2023 | 17.6% | +3.3 |
| Q2 FY2023 | Jun 30, 2023 | 18.5% | +6.5 |
| Q1 FY2023 | Mar 31, 2023 | 20.0% | +9.0 |
| Q4 FY2022 | Dec 31, 2022 | 17.7% | −2.1 |
| Q3 FY2022 | Sep 30, 2022 | 14.3% | +1.0 |
| Q2 FY2022 | Jun 30, 2022 | 12.0% | +2.9 |
| Q1 FY2022 | Mar 31, 2022 | 11.0% | −7.3 |
| Q4 FY2021 | Dec 31, 2021 | 19.8% | +110.4 |
| Q3 FY2021 | Sep 30, 2021 | 13.3% | −4.5 |
| Q2 FY2021 | Jun 30, 2021 | 9.0% | +9.9 |
| Q1 FY2021 | Mar 31, 2021 | 18.3% | +25.4 |
| Q4 FY2020 | Dec 31, 2020 | -90.6% | −77.3 |
| Q3 FY2020 | Sep 30, 2020 | 17.8% | −4.8 |
| Q2 FY2020 | Jun 30, 2020 | -0.8% | −23.7 |
| Q1 FY2020 | Mar 31, 2020 | -7.2% | −36.1 |
| Q4 FY2019 | Dec 31, 2019 | -13.3% | −32.7 |
| Q3 FY2019 | Sep 30, 2019 | 22.5% | −10.9 |
| Q2 FY2019 | Jun 30, 2019 | 22.8% | +16.3 |
| Q1 FY2019 | Mar 31, 2019 | 28.9% | +0.3 |
| Q4 FY2018 | Dec 31, 2018 | 19.4% | +62.1 |
| Q3 FY2018 | Sep 30, 2018 | 33.4% | +17.3 |
| Q2 FY2018 | Jun 30, 2018 | 6.5% | −11.3 |
| Q1 FY2018 | Mar 31, 2018 | 28.6% | −3.3 |
| Q4 FY2017 | Dec 31, 2017 | -42.7% | −59.8 |
| Q3 FY2017 | Sep 30, 2017 | 16.1% | – |
| Q2 FY2017 | Jun 30, 2017 | 17.8% | – |
| Q1 FY2017 | Mar 31, 2017 | 31.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 17.1% | – |
See a number that looks wrong?